MicroRNAs as Possible Biomarkers for Diagnosis and Therapy of Alzheimer’s Disease by Regulating the Abnormal Expression of Genes Related to Tau
Alzheimer’s disease (AD), the most common dementia with the symptom of deterioration of memory and cognitive functions, becomes one of the prevalent threats globally. Tau hyperphosphorylation is one of major risk factors of AD. At present, there is no effective treatment or quick diagnostic methods...
Main Author: | Tang Mengzhu |
---|---|
Format: | Article |
Language: | English |
Published: |
EDP Sciences
2023-01-01
|
Series: | BIO Web of Conferences |
Online Access: | https://www.bio-conferences.org/articles/bioconf/pdf/2023/05/bioconf_bfs2023_01001.pdf |
Similar Items
-
MicroRNAs: pioneering regulators in Alzheimer’s disease pathogenesis, diagnosis, and therapy
by: Yao-Bo Li, et al.
Published: (2024-09-01) -
MicroRNAs as Candidate Biomarkers for Alzheimer’s Disease
by: Colin Kanach, et al.
Published: (2021-02-01) -
The Regulation of microRNAs in Alzheimer's Disease
by: Xianjuan Kou, et al.
Published: (2020-04-01) -
MicroRNAs in Alzheimer’s Disease
by: Mengli Wang, et al.
Published: (2019-03-01) -
Plasma microRNAs as potential biomarkers in early Alzheimer disease expression
by: Carmen Peña-Bautista, et al.
Published: (2022-09-01)